All Immunology articles – Page 5
-
NewsStudy links multiple sclerosis with distinct oral microbiome
Researchers have produced the most comprehensive genetic and metabolic analysis to date of the oral microbiome associated with multiple sclerosis (MS). They found that people with MS have a distinct oral microbiome compared to healthy individuals.
-
CareersSummer studentship: Owen investigates how fungal hyphae interact with lung cells
Owen Nicholson reports back on his AMI-sponsored summer studentship which investigated the role of Piezo1 in the immune response during fungal invasion of the human lung at the University of East Anglia.
-
NewsDangerous E. coli strain blocks gut’s defense mechanism to spread infection
When harmful bacteria invade through the digestive tract, gut cells usually fight back by pushing infected cells out of the body to stop the infection from spreading. Scientists have discovered that a dangerous strain of E. coli can block gut this defense, allowing the bacteria to spread more easily.
-
NewsReport explores health, economic, and societal benefits of vaccination
A new report provides evidence on the advantages of immunization for individual and population health, economic outcomes, and societal well-being. Studies show that every $1 spent on childhood vaccines saves about $11 in avoided medical costs and preserved productivity.
-
NewsMosquito saliva may hold clues to fighting chikungunya inflammation
Scientists have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection - it not only transmits the virus but also influences how the body’s immune system responds.
-
News’Footprint of Death’ gives new clues to cell life, spread of disease
Scientists at La Trobe University have discovered a previously unknown way viruses could spread around the body, potentially paving the way for more effective drug development. Source: La Trobe University Dead cells after the self-destruction and fragmentation process. The large green areas are the “eat me” signals ...
-
NewsMiniature noses to help prevent infections and promote nasal health
To better understand how different bacteria interact with the lining of the human nose, researchers used a miniature model of the human nose to study how bacteria can live in nasal passages.
-
NewsNew monoclonal antibody shows promise for preventing malaria infections
A new early-stage clinical trial has found that a novel monoclonal antibody provided dose-dependent full protection against the malaria parasite with minimal side effects.
-
NewsStudy reveals how bacteria in tumors drive treatment resistance in cancer
Researchers have uncovered a previously unknown way for microbes within tumors to contribute to treatment resistance in certain cancers. The study finds these microbes push cancer cells into a reversible resting state, allowing them to become resistant to certain chemotherapies.
-
NewsResearch alert: Bacterial chatter slows wound healing
Researchers have discovered a previously unrecognized mechanism by which Staphylococcus aureus delays wound healing. The study finds that quorum sensing is a key driver of delayed healing in wounds infected by S. aureus.
-
NewsCombination of pre- and probiotics offers superior anti-inflammatory benefits compared with omega-3 or prebiotic alone
A new study has found that combining certain types of dietary supplements is more effective than single prebiotics or omega-3 in supporting immune and metabolic health, which could lower the risk of conditions linked to chronic inflammation.
-
NewsHuman Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy.
-
NewsSynthetic biology reprograms plant–microbe partnerships for resilient agriculture
By integrating engineering principles with plant biology, a new review highlights how redesigned genetic pathways and plant-based biosensors can deepen understanding of plant responses to both harmful and beneficial microbes.
-
NewsResearchers discover method to combat antibiotic treatment failure
Researchers explored ways to alter our own immune cells to help antibiotics work more effectively. They identified a small molecule that alters the body’s immune cells, forcing them to ’wake up’ dormant bacteria and make them more vulnerable to antibiotic treatment.
-
NewsCould cardamom seeds be a potential source of antiviral treatment?
Researchers have found that cardamom seed extract, as well as its main bioactive ingredient, 1,8-cineole, can have potent antiviral effects through its ability to enhance the production of antiviral molecules known as type I interferons via nucleic acid ‘sensors’ inside cells.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsNew study reveals diverse threats from Avian E. coli
New research has determined why various strains of Avian Pathogenic E. coli behave so differently. The study analysed a colibacillosis outbreak in turkeys in the UK, and found a strain called ST-101 was the dominant cause of the outbreak, accounting for nearly 60% of cases.
-
NewsCould targeted steroid use offer a universal complimentary treatment to fight TB?
Newly published research provides evidence that treating patients with steroids may enhance the function of their macrophages to kill the mycobacteria, while diminishing pathways of inflammatory damage.
-
NewsMeasles immunity 90% in BC’s Lower Mainland
In British Columbia’s Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study.
-
NewsTwo-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The results suggest individuals vaccinated with ZVL should be revaccinated with two doses of RZV.